{"title":"在某些癌症人群中,营养不良、低肌肉量和肌肉减少症可能被低估。案例:“一种方式,不适合所有人……患者的多样性”","authors":"Adele Hug, Susana Couto Irving","doi":"10.1159/000533514","DOIUrl":null,"url":null,"abstract":"<b>Background:</b> Low muscle mass (MM) is a common component of cancer-related malnutrition and sarcopenia, conditions that are all independently associated with an increased risk of mortality. This study aimed to (1) compare the prevalence of low MM, malnutrition, and sarcopenia and their association with survival in adults with cancer from the UK Biobank and (2) explore the influence of different allometric scaling (height [m<sup>2</sup>] or body mass index [BMI]) on low MM estimates. <b>Methods:</b> Participants in the UK Biobank with a cancer diagnosis within 2 years of the baseline assessment were identified. Low MM was estimated by appendicular lean soft tissue (ALST) from bioelectrical impedance analysis derived fat-free mass. Malnutrition was determined using the Global Leadership in Malnutrition criteria. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People criteria (version 2). All-cause mortality was determined from linked national mortality records. Cox-proportional hazards models were fitted to estimate the effect of low MM, malnutrition, and sarcopenia on all-cause mortality. <b>Results:</b> In total, 4122 adults with cancer (59.8 ± 7.1 years; 49.2% male) were included. Prevalence of low MM (8.0% vs. 1.7%), malnutrition (11.2% vs. 6.2%), and sarcopenia (1.4% vs. 0.2%) was higher when MM was adjusted using ALST/BMI compared with ALST/height<sup>2</sup>, respectively. Low MM using ALST/BMI identified more cases in participants with obesity (low MM 56.3% vs. 0%; malnutrition 50% vs. 18.5%; sarcopenia 50% vs. 0%). During a median 11.2 (interquartile range: 10.2, 12.0) years of follow up, 901 (21.7%) of the 4122 participants died, and of these, 744 (82.6%) deaths were cancer-specific All conditions were associated with a higher hazard of mortality using either method of MM adjustment: low MM (ALST/height<sup>2</sup>: HR 1.9 [95% CI 1.3, 2.8], P = 0.001; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; malnutrition (ALST/height<sup>2</sup>: HR 2.5 [95% CI 1.1, 1.7], P = 0.005; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; sarcopenia (ALST/height<sup>2</sup>: HR 2.9 [95% CI 1.3, 6.5], P = 0.013; ALST/BMI: HR 1.6 [95% CI 1.0, 2.4], P = 0.037).","PeriodicalId":17887,"journal":{"name":"Kompass Autoimmun","volume":"15 1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Malnutrition, Low Muscle Mass and Sarcopenia May be Underestimated in Certain Populations with Cancer. The Case For: “One Size, Does Not Fit All… Patient’s Diversity”\",\"authors\":\"Adele Hug, Susana Couto Irving\",\"doi\":\"10.1159/000533514\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<b>Background:</b> Low muscle mass (MM) is a common component of cancer-related malnutrition and sarcopenia, conditions that are all independently associated with an increased risk of mortality. This study aimed to (1) compare the prevalence of low MM, malnutrition, and sarcopenia and their association with survival in adults with cancer from the UK Biobank and (2) explore the influence of different allometric scaling (height [m<sup>2</sup>] or body mass index [BMI]) on low MM estimates. <b>Methods:</b> Participants in the UK Biobank with a cancer diagnosis within 2 years of the baseline assessment were identified. Low MM was estimated by appendicular lean soft tissue (ALST) from bioelectrical impedance analysis derived fat-free mass. Malnutrition was determined using the Global Leadership in Malnutrition criteria. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People criteria (version 2). All-cause mortality was determined from linked national mortality records. Cox-proportional hazards models were fitted to estimate the effect of low MM, malnutrition, and sarcopenia on all-cause mortality. <b>Results:</b> In total, 4122 adults with cancer (59.8 ± 7.1 years; 49.2% male) were included. Prevalence of low MM (8.0% vs. 1.7%), malnutrition (11.2% vs. 6.2%), and sarcopenia (1.4% vs. 0.2%) was higher when MM was adjusted using ALST/BMI compared with ALST/height<sup>2</sup>, respectively. Low MM using ALST/BMI identified more cases in participants with obesity (low MM 56.3% vs. 0%; malnutrition 50% vs. 18.5%; sarcopenia 50% vs. 0%). During a median 11.2 (interquartile range: 10.2, 12.0) years of follow up, 901 (21.7%) of the 4122 participants died, and of these, 744 (82.6%) deaths were cancer-specific All conditions were associated with a higher hazard of mortality using either method of MM adjustment: low MM (ALST/height<sup>2</sup>: HR 1.9 [95% CI 1.3, 2.8], P = 0.001; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; malnutrition (ALST/height<sup>2</sup>: HR 2.5 [95% CI 1.1, 1.7], P = 0.005; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; sarcopenia (ALST/height<sup>2</sup>: HR 2.9 [95% CI 1.3, 6.5], P = 0.013; ALST/BMI: HR 1.6 [95% CI 1.0, 2.4], P = 0.037).\",\"PeriodicalId\":17887,\"journal\":{\"name\":\"Kompass Autoimmun\",\"volume\":\"15 1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kompass Autoimmun\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000533514\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kompass Autoimmun","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000533514","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
& lt; b>背景:& lt; / b>低肌肉质量(MM)是癌症相关营养不良和肌肉减少症的常见组成部分,这些情况都与死亡风险增加独立相关。本研究旨在(1)比较来自英国生物银行(UK Biobank)的成人癌症患者中低MM、营养不良和肌肉减少症的患病率及其与生存率的关系;(2)探索不同异速测量尺度(身高[m<sup>2</sup>]或体重指数[BMI])对低MM估计的影响。& lt; b>方法:& lt; / b>英国生物银行的参与者在基线评估后2年内被诊断为癌症。通过生物电阻抗分析得出无脂质量,通过阑尾瘦软组织(ALST)估计低MM。营养不良是根据全球营养不良领导标准确定的。肌少症的定义采用欧洲老年人肌少症工作组标准(版本2)。全因死亡率根据相关的国家死亡率记录确定。拟合cox比例风险模型来估计低MM、营养不良和肌肉减少症对全因死亡率的影响。& lt; b>结果:& lt; / b>共有4122名成年癌症患者(59.8±7.1岁;49.2%为男性)。与ALST/身高sup>2< /sup>相比,使用ALST/BMI调整MM时,低MM(8.0%对1.7%)、营养不良(11.2%对6.2%)和肌肉减少症(1.4%对0.2%)的患病率更高。低MM使用ALST/BMI识别出更多的肥胖病例(低MM 56.3%对0%;营养不良50% vs. 18.5%;肌肉减少50% vs. 0%)。在中位随访11.2年(四分位数间距:10.2至12.0)期间,4122名参与者中有901人(21.7%)死亡,其中744人(82.6%)死亡是癌症特异性死亡。使用MM调整方法中的任何一种,所有疾病都与较高的死亡风险相关:低MM (ALST/height<sup>2</sup>: HR 1.9 [95% CI 1.3, 2.8], P = 0.001;Alst / bmi: hr 1.3 [95% ci 1.1, 1.7], p = 0.005;营养不良(ALST/height<sup>2</sup>: HR 2.5 [95% CI 1.1, 1.7], P = 0.005;Alst / bmi: hr 1.3 [95% ci 1.1, 1.7], p = 0.005;肌肉减少症(ALST/height<sup>2</sup>: HR 2.9 [95% CI 1.3, 6.5], P = 0.013;Alst / bmi: hr 1.6 [95% ci 1.0, 2.4], p = 0.037]。
Malnutrition, Low Muscle Mass and Sarcopenia May be Underestimated in Certain Populations with Cancer. The Case For: “One Size, Does Not Fit All… Patient’s Diversity”
Background: Low muscle mass (MM) is a common component of cancer-related malnutrition and sarcopenia, conditions that are all independently associated with an increased risk of mortality. This study aimed to (1) compare the prevalence of low MM, malnutrition, and sarcopenia and their association with survival in adults with cancer from the UK Biobank and (2) explore the influence of different allometric scaling (height [m2] or body mass index [BMI]) on low MM estimates. Methods: Participants in the UK Biobank with a cancer diagnosis within 2 years of the baseline assessment were identified. Low MM was estimated by appendicular lean soft tissue (ALST) from bioelectrical impedance analysis derived fat-free mass. Malnutrition was determined using the Global Leadership in Malnutrition criteria. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People criteria (version 2). All-cause mortality was determined from linked national mortality records. Cox-proportional hazards models were fitted to estimate the effect of low MM, malnutrition, and sarcopenia on all-cause mortality. Results: In total, 4122 adults with cancer (59.8 ± 7.1 years; 49.2% male) were included. Prevalence of low MM (8.0% vs. 1.7%), malnutrition (11.2% vs. 6.2%), and sarcopenia (1.4% vs. 0.2%) was higher when MM was adjusted using ALST/BMI compared with ALST/height2, respectively. Low MM using ALST/BMI identified more cases in participants with obesity (low MM 56.3% vs. 0%; malnutrition 50% vs. 18.5%; sarcopenia 50% vs. 0%). During a median 11.2 (interquartile range: 10.2, 12.0) years of follow up, 901 (21.7%) of the 4122 participants died, and of these, 744 (82.6%) deaths were cancer-specific All conditions were associated with a higher hazard of mortality using either method of MM adjustment: low MM (ALST/height2: HR 1.9 [95% CI 1.3, 2.8], P = 0.001; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; malnutrition (ALST/height2: HR 2.5 [95% CI 1.1, 1.7], P = 0.005; ALST/BMI: HR 1.3 [95% CI 1.1, 1.7], P = 0.005; sarcopenia (ALST/height2: HR 2.9 [95% CI 1.3, 6.5], P = 0.013; ALST/BMI: HR 1.6 [95% CI 1.0, 2.4], P = 0.037).